Express News Service
BENGALURU: An IISc (Indian Institute of Science) startup PathShodh Healthcare has made headway with its testing method for antibodies by receiving approvals to go ahead for production. The method is said to give a more precise quantative information on the pathogens present in one s body.
PathShodh has received the license to manufacture the test for sale from the Central Drugs Standard Control Organisation (CDSCO), after due diligence validation at the Translational Health Science and
Technology Institute (THSTI), Faridabad, as per the requirements of the Indian Council of Medical Research (ICMR), said a note by IISc on Tuesday.
Rabies Diagnostics Market Players Eye Lucrative Sales Opportunities in Developing Countries, Asia will Dominate the Market biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.
North America COVID-19 Diagnostics Market to be Driven by Liberalized Government Regulations in the Forecast Period of 2021-2026
iCrowd Newswire
The new report by Expert Market Research titled,
North America COVID-19 Diagnostics Market Size, Share, Price, Trends, Growth, Analysis, Report and Forecast 2021-2026 , gives an in-depth analysis of North America s COVID-19 Diagnostics Market, assessing the market based on its segments like test type, product, sample type, business mode, end use and major regions. The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price, along with analysing the market based on the SWOT and Porter s Five Forces models.